The QualityStocks Daily Newsletter for Wednesday December 2nd, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


OTC Picks (IFNY)


MicrocapVoice (ABCW)



The QualityStocks Daily

Cellceutix Corporation (CTIX)

SmallCap Voice, All Penny Stocks, and smallcap360 reported earlier on Cellceutix Corporation (CTIX) and we highlight the Company, here at the QualityStocks Daily Newsletter.

Cellceutix Corporation is a bio-pharmaceutical company that develops small-molecule therapies in areas of unmet medical needs. The Company owns the rights to seven drug compounds. These include Kevetrin, which they are developing as a treatment for certain cancers, and KM-133, which they are developing for psoriasis. Trading on the OTC Bulletin Board, Cellceutix Corporation has their corporate headquarters in Beverly, Massachusetts.

Cellceutix's main efforts are in cancer and inflammatory disease. The Company's founder, Dr. Krishna Menon, discovered Kevetrin, their lead product candidate. It has undergone extensive study (in vitro and in vivo) demonstrating potent anti-cancer activity against various cancer cell lines. 

Kevetrin's recent success in a series of animal model experiments with drug-resistant cancer cell lines has prompted Cellceutix Corporation to focus on Kevetrin's development potential in this area. Kevetrin is a small molecule that is water-soluble and simple to synthesize from commercially available starting materials.  The Company expects that it will undergo administering initially as an intravenous (IV) product.

Cellceutix filed a patent application covering Kevetrin in May of this year.  The patent application claims pharmaceutical formulations of Kevetrin in addition to novel compounds having similar structures to Kevetrin that may have potential as drug development candidates. The application also covers the use of Kevetrin and the other compounds in various disease states, including cancers.  The Company plans to file patent applications in other countries within a year of the U.S. filing. 

George Evans and Dr. Krishna Menon formed Cellceutix in May of 2007. The Company is developing the innovations of Dr. Menon and his team in the laboratory. Cellceutix owns intellectual property stemming from the inventions of Dr. Krishna Menon. His background consists of more than 35 years of experience working as team leader in drug development for top pharmaceutical companies and academic institutions.

Cellceutix Corporation announced in August that they acquired the rights to the compound KM 732, which shows properties in the reduction of high blood pressure. KM 732 is a small molecule that underwent development in a Cellceutix-affiliated laboratory in Pune, India. The compound will now undergo synthesis in the United States.

On November 2, 2009, Cellceutix Corporation announced that they concluded an agreement with Toxikon Corporation of Bedford, Massachusetts. This is to conduct the remaining preclinical studies required for an Investigational New Drug (IND) filing for their cancer drug Kevetrin™. The studies covered by the agreement are designed to confirm that Kevetrin meets FDA safety requirements for studies in humans. Toxikon Corporation is a life science company and a Contract Research Organization (CRO) that primarily conducts compliance studies for product safety.

Today, Cellceutix Corporation (CTIX) closed at $0.50 for no change. Volume was 13,000.

Gen2Media Corporation (GTWO)

Today, Investors Alley, OTC Picks, and SmallCap Voice reported on Gen2Media Corporation (GTWO)  Oxbury News Bulletin, The Green Baron, The Bull Report, Stealth Stocks, Super Stock Investor, The Stock Advisors, Market FN, Investment House, The Best Newsletters, The Online Investor, Monster Stock Picks, did earlier. In addition, MicroCap Gems, iStockAnalyst, SmallCap Sentinel, Emerging Markets, AlphaTrade, Standout Stocks reported previously, and we highlight the Company as "One to Watch", here at the QualityStocks Daily Newsletter.

Gen2Media Corporation is a fully integrated video technology, production, and marketing company. Trading on the OTC Bulletin Board, the company owns and operates the e360LIVE media network. This network reaches 20 million-plus viewers monthly through content syndication using their digital video publisher application and platform. The company works to embody the very best of broadcast and broadband.

Gen2Media’s video publishing technology enables businesses of all types to easily publish online video. It also helps them to manage media content and advertising delivery. Their proprietary and patent-pending technology has earned the trust of a growing, globally diversified customer base. These customers include leading media companies, corporations, chart-topping artists, entertainment companies, advertising agencies, and national brands.

Digital cinema pioneer Mary Spio and video innovators Mark Argenti and Ian McDaniel founded Gen2Media. The company creates, markets, and delivers content across a variety of platforms directly and through blue chip channel partnerships. These include Microsoft XBOX Live, Zune, TiVo, Clear Channel, Emmis, and other highly trafficked lifestyle and entertainment websites.

Gen2Media Corporation recently announced that Mailboat Records, Jimmy Buffet’s record label, selected them to help launch the new solo album by Joe Perry, lead guitarist for the rock band Aerosmith. Gen2Media is assisting in the online marketing initiative for Perry’s latest solo album “Have Guitar, Will Travel.” The contract provides for the marketing of the album across The Gen2 Network’s rock radio websites.

Last month, Gen2Media announced that President and Co-Founder Mary Spio received recognition as one of the 50 Most Important African Americans in Technology by San Francisco based publisher eAccess Corp. Ms. Spio, a former Boeing engineer and digital cinema pioneer, has been named to the 10th annual list.

Today, Gen2Media Corporation announced that they created a segment of the on-stage graphics for this evening's Black Eyed Peas performance at the GRAMMY Nominations Concert. Gen2 designed several screens of varying shapes and sizes used as the backdrop for the Black Eyed Peas performance.

"Gen2 continues to create digitally dazzling graphics for our clients. Having our finger on the pulse of the audience is essential as we design these spectacular experiences. We are the experts in the revolutionary use of video in all formats ---- be it online, on screen, or in-store," states Mary Spio, Co-Founder and President of Gen2Media Corporation.

We're tracking Gen2Media Corporation (GTWO) on our radar screens as "One to Watch", here at the QualityStocks Daily Newsletter.

Today, Gen2Media Corporation (GTWO) closed trading at $0.31 down 13.89 percent. Volume was 41,300.

Elite Pharmaceuticals Inc. (ELTP)

We are highlighting Elite Pharmaceuticals Inc. (ELTP), here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. The Company's strategy includes assisting partner companies in the life cycle management of products to improve off-patent drug products. Their strategy also includes developing generic versions of controlled release drug products with high barriers to entry. Founded in 1984, Elite Pharmaceuticals Inc. has their corporate headquarters in Northvale, New Jersey. Elite operates a GMP and DEA registered facility for research, development, and manufacturing in Northvale.

Elite Pharmaceuticals, Inc. specializes in products, such as delayed, sustained, targeted and pulsatile release tables, pellets, capsules, granules and powders.  Their primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection. Elite develops products that have high barriers to entry with regard to different factors. These factors include products with formulation complexities and products with regulatory challenges. These factors also include products requiring specialized release profiles and products with raw material problems. The Company normally develops these products through proof of concept. They then partner or license them out to fund their further development and for marketing.

Two of the Company's products, Lodrane 24® and Lodrane 24D®, are marketed by a partner, ECR Pharmaceuticals, for allergy treatment. Elite's lead pipeline products are novel sustained release oral formulations of oxycodone for the treatment of chronic pain. They address two of the limitations of existing oral opioids. These are the provision of consistent relief of baseline pain levels and deterrence of potential abuse. ELI-216, a once-daily abuse resistant oxycodone, and ELI-154, a once-daily oxycodone, are in late-stage development. Elite also has a generic gastrointestinal drug product in clinical development.

Today, Elite Pharmaceuticals, Inc. and ThePharmaNetwork, LLC announced the approval of an Abbreviated New Drug Application (ANDA) for methadone hydrochloride 10 mg tablets by the U.S. Food and Drug Administration (FDA). Elite and ThePharmaNetwork co-developed the product and the product was filed under ThePharmaNetwork name. The methadone hydrochloride tablets are the generic equivalent of the Dolophine® hydrochloride 10 mg tablets. Under the Product Collaboration Agreement, Elite will manufacture the product and Elite and ThePharmaNetwork, LLC will share in the profits from the sale of the product.

Elite Pharmaceuticals Inc. (ELTP) closed today's trading session at $0.14 up 39.90 percent. Volume was 7,031,244.

IntegraMed America Inc. (INMD)

We are highlighting IntegraMed America Inc. (INMD) today, here at the QualityStocks Daily Newsletter.

IntegraMed America Inc. is the nation's leading manager of specialty-outpatient healthcare facilities. This is in the emerging, technology-focused medical niches of fertility and vein care. Trading on the NASDAQ Global Market, the Company provides their networks with a full suite of management services and infrastructure. They also offer treatment financing for self–pay patients. IntegraMed America Inc. has their headquarters in Purchase, New York.

The Company manages highly specialized outpatient facilities. They are the leading manager of fertility centers and vein clinics in the United States. The Company supports their provider networks with clinical and business information systems, marketing and sales, and facilities and operations management. They also support them with finance and accounting, human resources, legal, risk management and quality assurance services.

IntegraMed's fertility network consists of 39 contracted centers with more than 100 locations in 34 states and the District of Columbia. Nearly one of every four IVF procedures in the U.S. takes place in an IntegraMed network fertility practice. The IntegraMed Vein Clinic network is the leading provider of varicose vein care services in the United States. This network operates 34 centers in 13 states, principally in the Midwest and Southeast.

Today, IntegraMed America, Inc. announced they have acquired Regents Management, and have entered into 25-year agreements with each of Regents' centers to provide them with IntegraMed's full range of fertility business, marketing and facility services. Regents Management manages three fertility centers in the Western United States.

IntegraMed expects the addition of the three centers to be immediately accretive to IntegraMed's overall reported earnings. The new centers expand IntegraMed's Fertility Center Network into three new markets and states. The centers consist of the Nevada Center for Reproductive Medicine in Reno, Nevada; the Idaho Center for Reproductive Medicine in Boise, Idaho; and the Utah Fertility Center, which will be in Pleasant Grove, Utah, outside Salt Lake City.

IntegraMed America Inc. (INMD) closed Wednesday's session at $7.55 down 1.69 percent. Volume was 3,625.

California Micro Devices Corp. (CAMD)

Today we choose to highlight California Micro Devices Corp. (CAMD), here at the QualityStocks Daily Newsletter.

Headquartered in Milpitas, California, California Micro Devices Corporation is a leading supplier of application specific analog and mixed signal semiconductor products. These products are for the mobile handset, high brightness LED (HBLED), digital consumer electronics and personal computer markets. The Company uses a direct sales force, manufacturers' representatives and distributors to sell their products. California Micro Devices Corp. trades on the NASDAQ Global Market.

The Company's key product lines include protection devices for mobile handsets, HBLEDs, digital consumer electronics products and personal computers and mixed signal ICs for mobile handset displays. The protection devices provide Electromagnetic Interference (EMI) filtering and Electrostatic Discharge (ESD) protection. California Micro Devices Corp. completely outsources their manufacturing. They use merchant foundries to fabricate their wafers and subcontractors to do backend processing and to ship to their customers.

End customers for their semiconductor products are original equipment manufacturers (OEMs). The Company sells to some of these end customers through original design manufacturers (ODMs) and contract electronics manufacturers (CEMs).

The Company's products and technology include The XtremeESD® family. This is made up of low capacitance, low profile ESD protection arrays featuring PicoGuard XP® and PicoGuard XS® architectures. XtremeESD products are for protection of high-speed serial interfaces in digital TVs and LCD display monitors such as MDDI, MIPI® or USB2.0 High-Speed.

Their Praetorian® ESD/EMI protection devices are multichannel LC EMI filters. They have ESD protection using spiral inductors combined with semiconductor circuit elements. They are suited for high-resolution display and camera interfaces in mobile handsets. Their LuxGuard™ family of ESD protection devices features silicon submounts and TVS diodes designed specifically for high power, high brightness LED applications.  Their Chip Scale Packages (CSP) offers a smaller footprint and lower cost than traditional plastic packages.

The Company's MediaGuard™ HDMI protection devices feature ESD protection for all 12 HDMI data lines plus level shifting, backdrive protection, and overcurrent protection for HDMI ports. This is for ports on digital TVs, cable and satellite settop boxes, DVD players and recorders, and other digital video devices. Their Centurion™ ESD/EMI protection devices include Zener diode ESD arrays plus multichannel RC EMI filters with ESD protection. This is for mobile handset applications including dataports and internal interfaces to displays and cameras.

California Micro Devices Corp. (CAMD) closed Wednesday's session at $3.01 down 1.95 percent. Volume was 12,734.

Bark Group Inc. (BKPG)

Yesterday, Global Equity Report, Penny Stock Explosion, The Green Baron, Monster Stock Alerts, Investor Guide, The Dean, and The Cervelle Group reported on Bark Group Inc. (BKPG). Investor Spec Sheet, Oxbury News Bulletin, Monster Stocks Picks, Capitalgainz did recently, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Bark Group Inc. is a multi-national European advertising company. As a communications company, their focus is on delivering cutting-edge advertising and marketing campaigns to leading businesses worldwide. The company has had great success throughout Scandinavia and Europe. Bark's objectives are to achieve aggressive growth through acquisition and development of satellite companies globally.  They are now looking to expand in the United States. Headquartered in Copenhagen, Denmark, Bark Group Inc. also has a New York City office.

Bark develops and delivers innovative, highly effective marketing campaigns on strategic, emotional and creative levels to clients globally. The campaigns they create integrate classic and digital media as well as viral and other forms of communication. This integrated approach offers their clients a higher return on their advertising investments.

The Company collaborates with Mindmetic, a mind research company that is developing neuro-marketing research methods. Mindmetic studies and develops methods for interpreting and decoding conscious and subconscious human emotions that arise when people are subjected to different messages. Bark Group Inc. is working to leverage this research and use it in their marketing campaigns.

In August of this year, Bark Group Inc. reported that SimCorp A/S engaged Bark Group for their innovative advertising, media and communications strategies. SimCorp A/S is a leading international financial software company. SimCorp A/S provides highly specialized investment management software for leading fund and investment management companies, pension funds, banks and insurance companies.

Today, Bark Group Inc. announced that their primary subsidiary Bark Copenhagen expects to report positive net income for the Fiscal Year ending December 31, 2009. The announcement is based on greater-than-expected income due to a surge in new clients in the current quarter.

Anders Hageskov, CEO of Bark Group, stated, "We are, of course, very pleased with these results for Bark Copenhagen. It seems that our integrated media, Internet and advertising strategy are appealing to the market in Denmark and Europe, and the response has moved our subsidiary quickly into the black."

Today, Bark Group Inc. (BKPG) closed at $0.60 up 9.09 percent. Volume was 743,659.

America West Resources, Inc. (AWSR)

OTC Picks reported recently on America West Resources, Inc. (AWSR), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

America West Resources, Inc. is a domestic compliant coal producer with mining operations in Central Utah. The Company is an established domestic coal producer focused on the mining of compliant (low-sulfur) coal and its sale. This is primarily to U.S. utility companies for use in generating electricity. America West Resources, Inc. operates the Horizon Mine, near Helper, Utah, in continuous operations since 2003. This mine has recoverable compliant coal reserves under lease of approximately 19 million tons. America West Resources, Inc. trades on the OTC Bulletin Board and they have their headquarters in Salt Lake City, Utah.

The Company's strategy is to pursue their acquisition targets in the Western United States region in the near future. This is in order to help build substantial reserves and obtain economies of scale.  Their strategy is also to significantly reduce shipping costs and construct a coal wash plant. This is in order to advance their cost effectiveness while generating more revenue by assisting other small miners in the region. In addition, the Company's strategy is to deliver coal economically by building a coal terminal for rail transit.

Coal from America West Resources, Inc.'s Horizon Mine is a high quality, cost-effective product. It is a bituminous coal high in energy content. It is low in sulfur, moisture, and ash. The mine is truck and rail accessible though the BNSF, UPRR, and Utah Railroads. Any combination of rail/barge/ship is available to deliver Horizon coal to domestic and international users/buyers.

Today, America West Resources, Inc. announced that they signed a binding Letter of Intent. This is to acquire the coking coal operations (Luxin) of Shanxi Jiexiu Luxin Coal Gasification Company (Shanxi Jiexiu), an established diversified holdings company based in Shanxi Province, China, which also owns coalmines and a major coal trading operation. Luxin operates a modern coking coal plant in Shanxi Province with annual production capacity of 600,000 metric tons.

Dan Baker, Chief Executive Officer of America West Resources, stated, "Through the acquisition of the majority interest in Luxin and the vertical integration of its coking coal plant into our operating platform, America West effectively diversifies our business, establishes a critical gateway to China, and materially strengthens our financial profile."

America West Resources, Inc. (AWSR) closed Wednesday's trading session at $0.10 up 42.86 percent. Volume was 368,788.

TX Holdings Inc. (TXHG)

Today we are highlighting TX Holdings Inc. (TXHG), here at the QualityStocks Daily Newsletter.

Incorporated in 2000, TX Holdings Inc. is a developing oil and gas production company. The Company is actively acquiring producing and non-producing shallow, low risk oil and gas leases in the Abilene area of West Texas. Headquartered in Ashland, Kentucky, they are concentrating on acquisitions in the Eastland and Callahan County regions of West Texas, located between Fort Worth and Midland. TX Holdings Inc. trades on the OTCBB.

TX Holdings Inc. is focusing their efforts strictly on these areas presently. This is because the Company wants to maximize the yield and existing resources in order to optimize the time and money spent on developing production from their leases. They have put in place the necessary work program to meet the Texas Railroad Commission requirements. They are working to institute a well-by-well strategy to sequence the coming on line of each individual well. Upon having this program bedded down, they will start to install a fracturing and flooding schedule to maximize the production output.

TX Holdings Inc.'s property interests include 8 percent working interest in the Contract Area; 75 percent working interest in the Park's Lease; and 100 percent working interest in the Williams Lease, in the counties of Callahan and Eastland. Pursuant to a previously acquired option to purchase, the Company successfully purchased the working interest in the three Williams Leases. These are the "Louie Williams," the Williams "A" and the Williams "B." The acreage is near Abilene, Texas.

In the Contract Area 1 the leases are "Roy Adams" (160 acres); "Isenhower" (20 acres); Isenhower Estate "C" (22 acres); and the W. Isenhower Estate. The Park's Lease is 320 acres. It has approximately 22 existing wells and estimated recoverable reserves of 12M to 13M barrels and it is next to the Williams Leases. The Company's future objectives include a desire to continue to expand their acquisition and development programs at the same high levels of density per acre in the immediate future. 

TX Holdings Inc. (TXHG) closed Wednesday's session at $0.10 up 33.33 percent. Volume was 218,443.

The QualityStocks Company Corner


The QualityStocks Daily Newsletter would like to spotlight VIASPACE (VSPC) Today, VIASPACE closed trading at $0.0260, which was up 8.33 percent. Their volume today was 1,197,276 shares.

VIASPACE (VSPC) announced that the first harvest of Giant King Grass is complete and that a new grass processing and storage facility is under construction on company land in China.

VIASPACE (VSPC) a clean energy company growing Giant King™ Grass as a low-carbon, renewable energy crop, today provided an update on the status of the initial public offering of their majority owned subsidiary VIASPACE Green Energy.

VIASPACE (VSPC) is a clean energy company focused on providing products and technology that reduce or eliminate dependence on fossil fuels and other high-pollutant energy sources. Through its subsidiaries, the company provides raw material for cellulosic biofuels; develops and markets fuel cartridges, products and technology for methanol fuel cells; markets rechargeable lithium-ion batteries; and develops security-related monitoring and detection technology and systems for military/defense and commercial applications.

Through its renewable energy subsidiary, VIASPACE Green Energy, the company grows a fast-growing non-food grass that can be harvested four times a year. This proprietary grass is used for producing low carbon liquid biofuels such as cellulosic ethanol, methanol and green gasoline for transportation, as well as partially or completely replacing coal to reduce carbon emissions from electric power plants. Cellulosic biofuels made from non-food sources offer environmental and economic advantages over food crops, like corn, and are attracting strong political support around the world.

Through its alternative energy subsidiary, Direct Methanol Fuel Cell Corporation, the company designs and manufactures disposable methanol fuel cartridges that supply power for portable electronics such as notebook computers and mobile phones. Compared to traditional batteries, fuel cells cleanly and efficiently convert methanol into electricity without burning and provide longer operating time and instantaneous recharging. VIASPACE also supplies rechargeable lithium batteries for electronics, power tools, electric bicycles and other electric vehicles.

Through its high-technology subsidiary, Ionfinity, the company collaborates with Caltech and NASA’s Jet Propulsion Laboratory to develop and commercialize new sensor technology that can detect very small amounts of hazardous materials such as explosives, chemical/biological weapons, toxic gases and drugs. Leveraging Ionfinity’s miniaturization technology, new portable monitoring devices and detection systems are being developed for homeland security, defense, biomedical, industrial process control, agricultural and environmental safety applications. Disclaimer



First Giant King Grass Harvest

VIASPACE Expands Giant King(TM) Grass Production Capacity

VIASPACE Files Amended Form S-1

General Environmental Management (GEVI)

The QualityStocks Daily Newsletter would like to spotlight General Environmental Management Inc. (GEVI) Today, General Environmental Management Inc. closed trading at $0.34, for no change. Their volume today was 41,531 shares.

General Environmental Management Inc. (GEVI) announced that it has filed its 10Q Report for the quarter ended September 30, 2009. The company also provided a brief update on the previously announced closing of the acquisition of Santa Clara Waste Water Company, as well as the progress made on the sale of GEM’s field services business.

General Environmental Management Inc. (GEVI) is in the process of shifting its business focus from hazardous waste field services to the fast growing water treatment and waste-to-energy markets. Since its inception in 2002, the Company has grown at a compounded annual rate of 48% to generate annual revenues of $37M from only $2.3M.

This strategic decision was made after an all inclusive analysis of GEVI's opportunity in the environmental management business. Although the company could work through the current economic downturn and build revenue in its field services business, they believe that shareholders will be rewarded by moving the company into the higher margin, faster growing business segments.

Within the U.S. alone, the water industry is a $120 Billion market that is expected to grow at 6-7% over the next year. On a global basis, the industry size exceeds $400 billion annually and increasing with the demands of a growing world population. The global waste-to-energy market, on the other hand, is a $19.9 billion market with expected CAGR of 6.7% over the next five years.

In order to ensure every advantageous acquisition opportunity is properly evaluated, GEVI has retained the services of General Pacific Partners (GPP). With a very selective and calculated acquisition strategy in place, GEVI is poised for continued success. Disclaimer

General Environmental Management Inc. Blog

General Environmental Management Inc. News:

General Environmental Management Announces Release of Quarterly Report

Reminder Notice: General Environmental Management Investor Conference Call 12/2/09 at 4:30pm EST

General Environmental Management Announces Completion of Acquisition of Santa Clara Waste Water

eDOORWAYS Corporation (EDWY)

The QualityStocks Daily Newsletter would like to spotlight eDOORWAYS Corporation (EDWY) Today, eDOORWAYS Corp. closed trading at $0.0720, which was down 5.26 percent. Their volume today was 3,306,197 shares.

eDOORWAYS Corp. (EDWY) has engaged Telcordia Technologies Inc., a global leader in the development of fixed, mobile and broadband communications software and services for Communications Service Providers (CSPs), enterprises, suppliers and government entities, to aid in the development and implementation of its Web 3.0 services platform.

eDOORWAYS Corp. (EDWY) is committed to solving lifestyle problems for consumers while driving traffic to suppliers and service providers who offer innovative merchandise and solutions. The company has the potential to completely change the future landscape of business by offering a unique and comprehensive service that saves consumers valuable time and money. By uniting a consumer with the larger global consumer community, retailers, and manufacturers in an effective new way, eDOORWAYS promotes “dynamic” commerce, as opposed to the static model currently in existence.

The Company plans to capitalize on several emerging new trends. These newly created opportunities include: the large success of Web 2.0 Internet community service offerings such as MySpace, the movement towards niche marketing and targeted advertising, the introduction of new technologies that enable instantaneous, online presentation of information, and the rising consumer preference for using the Internet to gain information before making purchasing decisions.

eDOORWAYS plans to introduce local services using a city-by-city strategy that will minimize capital requirements, reduce staffing requirements, and optimize generated revenues. Ten major cities are targeted for launch in the first year. Advertising, PR campaigns and viral word-of-mouth will be used to give a public presentation to experts as well as educate the market.

The key benefits offered to consumers include a higher level of engagement with vendors, trusted information from other consumers, and superior customer service. Revenues will be generated through advertising placement fees, premium services, preferential placement fees, and a percentage of sales transactions. eDOORWAYS' progressive vision and professional management team makes it an attractive investment opportunity. Disclaimer

eDOORWAYS Corporation Blog

eDOORWAYS Corporation News:

eDoorways Hires Telcordia to Begin Prep Work on Its Web 3.0 Model

eDoorways Accelerates Platform's Web 3.0 Integration With Move to Drupal

eDoorways Strikes Gold With Social Media Marketing

Muscle Flex Inc. (MFLI)

The QualityStocks Daily Newsletter would like to spotlight Muscle Flex Inc. (MFLI). Today, Muscle Flex Inc. closed trading at $0.0190, which was down 5.00 percent. Their volume today was 814,780 shares.

Muscle Flex Inc. (MFLI) announced that they have launched www.BeagleStepFit.com, a customer support site ahead of the Beagle StepFit national commercial release on December 7, 2009. The site contains detailed product information and instructions on the use of the Beagle StepFit and Beagle Mini pedometer.

Muscle Flex Inc. (MFLI) is a leading edge fitness, health and lifestyle company focused on developing exciting brands and new products to market using direct response TV advertising and infomercials as well as cutting edge brand and image marketing. The company has designed all its products with the average person's lifestyle in mind.

Muscle Flex Inc. VATA Brasil sports and active wear collection is an ultra comfortable active wear line that utilizes superior moisture control fabric. The VATA Brasil OneFit fabric is an amazing innovation in sporting wear apparel, offering the advantages of being lightweight, highly elastic, and having four times the filaments than regular fabric.

The company’s newest product, The BUDDY Tablet Caddy™, is a personal, compact and portable tablet caddy with three individual compartments and a digital timer to remind users when it’s time to take vitamins or prescriptions. The pharmacist approved tablet caddy ensures the maximum effectiveness of all medications and supplements.

Founder and CEO Danny Alex leads the company with nearly three decades of experience in the health, fitness and athletic lifestyle. Since a young age, regular exercising and maintaining a healthy lifestyle has been a key part of Danny’s life. Today, it is his passion to help others get excited about themselves through fitness and healthy living. Disclaimer

Muscle Flex Inc. Blog

Muscle Flex Inc. News:

Acquires MuscleFlex.com and Launches an Updated Web Site Ahead of the Beagle StepFit National Commercial Release December 7, 2009

Muscle Flex to Release the BUDDY Tablet Caddy Two-Minute Commercial and Landing Page at 8pm PST Friday, November 20, 2009 at GetTheBUDDY.com

Tune Into MuscleFlexInc.com for the American Music Awards Online Pre-Show Sunday, November 22, 2009 From 3:00 - 5:00 PM Broadcast Live From the Red Carpet at the Nokia Theatre With Muscle Flex CEO Danny Alex as the Official Fitness and Lifestyle Expert Commentator

Newport Digital Technologies, Inc. (NPDT)

The QualityStocks Daily Newsletter would like to spotlight Newport Digital Technologies, Inc. (NPDT). Today, Newport Digital Technologies, Inc. closed trading at $0.0265, which was up 8.16 percent. Their volume today was 2,223,857 shares.

Newport Digital Technologies, Inc. (NPDT) offers a rich portfolio of competencies in RFID (Radio-Frequency Identification), WiMAX, eLearning, LED Signage, and Security & Surveillance. Utilizing its technological expertise and creativity, the company enables its customers to take full advantage of the nearly limitless possibilities offered by increasingly sophisticated applications.

Newport is committed to meeting specific customer requirements by delivering complete solutions for a broad spectrum of applications. The company is building a global distribution, licensing, and sales network of industry-leading partners as well as third-party Original Design Manufacturers (ODMs) and component suppliers to ensure its clients world-leading technology with strong local support capabilities.

The company has established a synergistic partnership with Taiwan’s premier technology incubators, the Institute for Information Industry (III) and the Industrial Technology Research Institute (ITRI), under which the company develops and customizes their advanced technologies to meet the needs of businesses across the globe. Having a pool of more than 7,900 engineers and scientists, these R&D powerhouses have developed cutting edge capabilities in fields such as Information Communications Technology (ICT), electronics, and nanotechnology.

Newport’s management team has accumulated a wealth of knowledge and experience within the technology industry as well as the corporate world. Maintaining a strong track record of delivering results to investors and customers, the team retains over two centuries of combined experience. Leveraging each team member’s area of expertise, Newport has established a solid foundation to penetrate emerging technology markets.Disclaimer

Newport Digital Technologies, Inc. Message Board

Newport Digital Technologies, Inc. Blog

Newport Digital Technologies, Inc. News:

SCIA "Saturday Winter Conference" Dec. 5th Hilton Hotel, Irvine, CA

SmallCapSentinel.com: Report on Information Technology Innovator Published

Newport Digital Technologies to Implement Microsoft Licensing Agreement; Prepares to Launch First Ruggedized RFID Reader with the Windows Mobile Operating System

TapImmune, Inc. (TPIV)

The QualityStocks Daily Newsletter would like to spotlight TapImmune, Inc. (TPIV) Today, TapImmune, Inc. closed trading at $0.4790, which was up 6.44 percent. Their volume today was 18,876 shares.

Today, SectorWatch.biz reported that vaccines are projected as leading Pharma growth drivers. Several recent reports indicate that the vaccine marketplace will show big gains through 2012. This bodes well for companies such as TapImmune Inc. who specializes in the development of cell-based immunotherapeutics and vaccines in the areas of oncology and infectious disease.

TapImmune, Inc. (TPIV) is a biotechnology company focused on developing innovative therapeutics and vaccines in the areas of oncology and infectious disease. The company’s lead product, the TAP vaccine, is a key componesnt of a mechanism that moves characteristic markers called antigens to the surfaces of cells. Without TAP, there is a large reduction in presentation of cancer markers, making it impossible for the immune system to spot rogue cells and cancerous cells, allowing them to grow undetected.

The company’s vaccine has demonstrated its effectiveness in restoring TAP which in-turn restores and augments the characteristic marker (antigen) and subsequent recognition and killing of cancer cells by the immune system. The TAP molecule also works to enhance targeted vaccines against infectious diseases. For example, including TAP in the studied Smallpox Vaccine showed potency was increased by 100-1,000 times.

TapImmune, Inc. (TPIV) technologies have broad applications in developing therapeutic and preventative vaccines. The company’s technologies have been featured on ABC News BusinessNow, B-TV, in BusinessWeek, Popular Mechanics and local news papers as well as many respected medical journals including the Journal of Immunology, Nature (Biotechnology), International Journal of Cancer, Cancer Research and PLoS Pathogens, among others.

Management believes that its cancer vaccine strategy is a unique therapeutic approach that addresses the problem of poor immune responses to cancer. Since restoring the TAP protein directs the body’s immune system to specifically target cancerous cells without damaging healthy tissue, this therapy potentially has a strong competitive advantage over other cancer therapies. Disclaimer

TapImmune Blog

TapImmune, Inc. News:

TapImmune Announces Additional Funding

SectorWatch.biz: Vaccines Projected as Leading Pharma Growth Driver

TapImmune, Inc. to be Featured in Small Cap Stock Newsletter QualityStocks Daily

General Environmental Management, Inc. (GEVI) Files Quarterly Report; Updates Investor Community

General Environmental Management, Inc. announced today just before market close that it has filed its 10Q Report for the quarter ended September 30, 2009. The Form 10Q can be found at http://www.sec.gov.
The company also provided a brief update on the previously announced closing of the acquisition of Santa Clara Waste Water Company, as well as the progress made on the sale of GEM’s field services business.

According to the press release, GEM has taken major actions to eliminate debt, improve GEM’s balance sheet and free up resources to focus on new, profitable markets. To date, the company has: 1) sold GEM Mobile Treatment Services, Inc.; 2) acquired Santa Clara Waste Water Company (SCWW), a profitable, 50-year-old wastewater treatment business; and, most recently 3) executed a definitive agreement to sell the field services business unit for $14 million in cash plus the assumption of $1.1 million of long-term lease obligations. The net cash proceeds from the transaction will be used to retire senior debt and to pursue the company’s new business strategy in the water treatment and waste-to-energy markets.

“Taken together, these strategic moves have created a foundation for GEM to take advantage of opportunities that we believe will lead to profitability and positive cash flow in the coming year,” stated Koziol. “Our shareholders should look at the current quarterly report as a reflection of a work in progress. Our intention is to continue to focus on higher margin business opportunities in the water treatment and waste-to-energy markets in order to maximize shareholder value of our company’s stock. We are very pleased with the progress and advancements the company has made the past few months, especially when considering the difficult economic environment.”

Koziol added, “In regards to the sale of our field services business, we have reached an agreement with Luntz Acquisition (Delaware), LLC, a subsidiary of PSC Environmental Services, LLC, to sell General Environmental Management, Inc. (DE) and its subsidiaries, which include five service centers, the TSDF of GEM Rancho Cordova LLC, and the Island Environmental Services business. The final purchase price will be subject to an adjustment based on the computation of net working capital at closing. We have agreed upon a closing date on or prior to March 1, 2010, subject to the approval of GEM’s shareholders.”
He further stated, “Concluding the sale of our field services business will result in a dramatic improvement of our balance sheet, and will result in a lean business that will put profitability and cash generation as the top priorities. We firmly believe our hard work will pay off once we’ve fully transitioned to the faster-growing water treatment and waste-to-energy markets. After the foundation is laid, we will focus our efforts on building a regional and then national presence.”

General Environmental Management Inc. also reminded the investment community that it will be hosting its first-ever investor conference call today at 4:30 EST / 1:30 PST. After prepared remarks and presentation of the operating results, the call will be open to questions and answers. During the earnings call, General Environmental Management, Inc. will provide detailed information on the acquisition of Santa Clara Waste Water Company (SCWW). GEM Management will also discuss the company’s efforts to acquire, license or partner with waste-to-energy technologies and companies.

TapImmune, Inc. (TPIV.OB) Signs License Agreement with Crucell (CRXL)

TapImmune Inc., best known for developing immunotherapeutic vaccines for cancer and infectious diseases, announced recently that it has signed a license agreement with Crucell N.V. (NASDAQ: CRXL), a global biopharmaceutical company based in the Netherlands. The license allows TapImmune to use Crucell’s proprietary PER.C6® cells in its development programs.

The cell line is ideal for the development and large-scale production of a wide variety of biopharmaceuticals. Specifically, PER.C6 cells do not generate replication competent adenoviruses in the use of recombinant vaccines using adenoviral vectors, making it excellent for the production of adenoviral vectors for clinical applications. Generally, the PER.C6 cell line is the best documented line for vaccine development to date. Its extensive Biologics Master File at the U.S. FDA can be cross-referenced by licensees, resulting in simplification and acceleration of the IND filing and approval process.

The agreement is important for the production of TapImmune’s vaccine products. TapImmune’s primary product candidate, the AdhTAP vaccine enhancer, is designed to help the body’s immune system identify cancer cells so that it can destroy them. It does this by restoring and augmenting antigen presentation and subsequent recognition and killing of cancer cells by the immune system. TapImmune is currently planning for the commencement of clinical manufacturing and toxicology studies.

TapImmune is also developing a TAP based prophylactic vaccine, which initial tests indicate may increase the efficacy of targeted prophylactic vaccines by as much as 1,000 times. As a vaccine, TAP technology could be significant in the fight against many pandemic infectious diseases. As a cancer therapy, TAP vaccine could prove to be a key component in a more successful assault on cancer.

The partnership between TapImmune and Crucell also gives Crucell the right to negotiate a license for TapImmune’s TAP technologies for infectious disease indications.


Sponsors of the Day


The QualityStocks Public Company Sponsor News



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336